The audiology and public health researcher will fill the newly created role of vice president of audiology innovation and research.
Amplifon, parent company of Miracle-Ear, has appointed Nicholas Reed, AuD, PhD, to the newly created role of vice president of audiology innovation and research. In this position, Dr Reed will oversee Amplifon’s research initiatives and support the company’s efforts in audiology and hearing health.
Dr Reed is an internationally recognized researcher in audiology and public health, with work focused on bridging the gap between clinical audiology and population health. His research has highlighted the link between hearing loss and broader healthcare outcomes, including cognitive decline. He has previously held academic positions at NYU Grossman School of Medicine and Johns Hopkins University and has more than 200 publications.
“We are honored to welcome Dr Nicholas Reed to our team. His reputation as a world-class researcher and his profound knowledge of hearing health make him the ideal person to lead our research initiatives in audiology,” says Enrico Vita, chief executive officer of Amplifon, in a release. “His appointment represents a significant investment by Amplifon in the future of hearing care: by integrating Dr Reed’s expertise in epidemiology and clinical audiology, we will further refine our protocols and make our services even more innovative, personalized, and effective, with the goal of improving the quality of life for millions of people worldwide.”
“I have spent my career striving to ensure that research makes a tangible difference in people’s lives. Joining Amplifon provides a unique global platform to scale that mission,” says Dr Reed, in a release. “I am excited to support the company’s efforts in health innovation, fostering closer ties with the scientific community to ensure that every individual has access to the highest quality, evidence-based hearing care.”
Dr Reed will be based at Amplifon Americas’ headquarters in Minneapolis.
